XBiotech Inc..
XBIT.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products
XBiotech Inc. is a fully integrated global biosciences company dedicated to pioneering the discovery, development, and commercialization of therapeutic antibodies. The company focuses on developing True Human™ antibodies to treat diseases by targeting fundamental disease processes. XBiotech's lead p...Show More
Better Health for All
0
No evidence available to assess XBiotech Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
XBiotech Inc. is a biosciences company focused on developing therapeutic antibodies.
1
The provided articles do not contain any evidence that the company offers lending, deposit, insurance, or other financial products or services to consumers or businesses. Therefore, all KPIs related to 'Fair Money & Economic Opportunity' are not applicable to XBiotech Inc., as its core business lies outside the financial services sector.
Fair Pay & Worker Respect
-20
In 2023, XBiotech Inc. reported a CEO-to-median employee pay ratio of 55:1, with the median employee pay at $100,548.
1
Employee reviews on Glassdoor indicate an average rating of 2.9 out of 5 stars.
2
Reviews also state that compensation and benefits are rated 2.8 out of 5, with multiple employees citing significantly below-market salaries, no 401k matching, and a lack of family health insurance.
3
Reviews explicitly indicate no or limited employer-funded health insurance.
4
Fair Trade & Ethical Sourcing
0
No evidence available to assess XBiotech Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
-20
XBiotech Inc. has a Code of Business Conduct and Ethics applicable to all directors, officers, and employees, promoting honest and ethical conduct, fair dealing, and compliance.
1
The company provides a confidential and anonymous financial concern hotline for accounting, internal accounting controls, or auditing matters, and users can access the status of their messages via a 14 to 16-digit code.
2
The Audit Committee is responsible for investigating violations of the Code.
3
The company also has an Insider Trading Policy and a Clawback Policy.
4
The board includes independent and disinterested directors who negotiated and approved a loan.
5
However, as of March 18, 2025, directors, executive officers, and principal shareholders beneficially own approximately 44.2% of outstanding common stock.
6
The company reported numerous enrollment irregularities and widespread improprieties at clinical sites in its Rheumatology program, rendering the data uninterpretable.
7
Kind to Animals
-60
XBiotech uses a new animal research facility and conducts ongoing *in vivo* testing, including animal toxicology studies required by the FDA.
1
There is no evidence of the company employing non-animal testing methods for product safety and efficacy.
2
XBiotech is listed as a company that engages in animal testing, and its policy is vague, with no measurable goals for reduction.
3
The company's construction of a subterranean parking garage aims to minimize its ecological footprint and preserve existing woodland on its 48-acre campus, but this is a general environmental impact reduction, not a measurable biodiversity conservation initiative with species recovery or habitat restoration metrics.
4
The company's technology captures native antibody sequences from human donors, but there is no evidence of participation in multi-stakeholder initiatives to develop industry-wide animal-free testing or sourcing standards.
5
No quantitative data on animal testing volume or reduction goals is provided for XBiotech.
6
No War, No Weapons
0
No evidence available to assess XBiotech Inc. on No War, No Weapons.
Planet-Friendly Business
0
No specific, concrete data points or facts were found in the provided articles to assess XBiotech Inc. against any of the 'Planet-Friendly Business' KPIs. The articles either explicitly state a lack of information for these metrics or focus on other aspects of the company without providing the required quantitative environmental performance data.
1
Respect for Cultures & Communities
0
No specific, concrete data points were found in the provided articles regarding XBiotech Inc.'s performance on any of the KPIs related to 'Respect for Cultures & Communities'. The articles either discuss general industry trends or focus on company career opportunities and technology, without providing information on community engagement, cultural impact, or related metrics for XBIT.US.
Safe & Smart Tech
0
No evidence available to assess XBiotech Inc. on Safe & Smart Tech.
Zero Waste & Sustainable Products
0
No specific, concrete data points were found in the provided article to assess XBIT.US against any of the 'Zero Waste & Sustainable Products' KPIs.
1
The article explicitly stated 'No data is available for XBIT.US or Zero Waste & Sustainable Products' due to a 'Page Not Found' error.
2